國家衛健委:促進中醫藥傳承創新發展 推建國家醫學中心
國家衛健委等六部門印發深化醫藥衛生體制改革2023年下半年重點工作任務提出,將促進中醫藥傳承創新發展。加快國家中醫藥傳承創新中心、國家中醫疫病防治基地、中醫特色重點醫院、中西醫協同「旗艦」醫院建設,推進國家中醫藥綜合改革示範區建設。加強中醫醫院康復科和老年醫學科建設,建設一批中醫康復中心。加強中醫藥特色人才培養,面向基層醫療衛生機構醫師和鄉村醫生開展中醫藥知識技能培訓。
同時,將推進國家醫學中心和國家區域醫療中心設置建設,統籌佈局綜合類、專科類、中醫類的國家醫學中心建設項目,開展國家區域醫療中心建設成效評價,推動建立與國家區域醫療中心相適應的管理體制和運行機制。
此外,提出要深化公立醫院薪酬制度改革。在覈定的薪酬總量內,公立醫院可採取多種方式自主分配,合理確定內部薪酬結構,嚴禁向科室和醫務人員下達創收指標,醫務人員薪酬不得與藥品、衛生材料、檢查、化驗等業務收入掛鉤,並探索實行公立醫院主要負責人年薪制等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.